Target intelligence / Profile preview

Uropathogenic Escherichia coli outer membrane

Molecular classification
Outer membrane, Bacterial membrane structure, Lipopolysaccharide complex, Protein-lipid bilayer, Other
01

Overview

The **Uropathogenic Escherichia coli outer membrane** is a specialized, complex lipid bilayer structure unique to Gram-negative bacteria such as UPEC. This membrane consists predominantly of **phospholipids**, **lipopolysaccharides (LPS)**, and a variety of **outer membrane proteins** and **adhesive organelles** (including pili and fimbriae). It functions as a critical **barrier to antibiotics and host immune molecules**, mediates **adhesion to uroepithelial cells** (via fimbrial adhesins, such as type 1 fimbriae and P pili), and supports the secretion or surface presentation of **virulence factors** that are essential for establishing **urinary tract infections (UTIs)**. LPS in the outer membrane directly impacts susceptibility to antibiotics, especially cationic antimicrobial peptides and polymyxins, and is immunogenic in the host, sometimes leading to inflammatory responses. As a multi-component structure, "Uropathogenic Escherichia coli bacterial membrane" is not a single molecular target, but rather a collection of structural and functional elements critical for UPEC pathogenesis, antibiotic resistance, and immune modulation[1][2][3][4][5][6]. **Note:** - The input "Uropathogenic Escherichia coli bacterial membrane" is not a canonical designation for a single druggable target; it describes a complex structure with multiple relevant pharmacological targets (e.g., LPS, porins, specific membrane proteins). Use with caution, and future queries may benefit from specifying individual components such as "UPEC lipopolysaccharide," "UPEC outer membrane protein A," or "UPEC type 1 pilus." - If a precise, individual molecular target is needed for structured databases, select one of the well-characterized surface proteins or LPS. - This entry is flagged as potentially **incorrect for structure-based or biomarker databases** since it is not a distinct, single molecule but a macromolecular assembly.

Other names
UPEC outer membraneEscherichia coli outer membrane (uropathogenic strain)UPEC membraneE. coli outer membrane (UPEC)UPEC cell envelope
02

Mechanism of action

Disruption of membrane integrity; Increased membrane permeability; Displacement of stabilizing cations in the outer membrane; Inhibition of outer membrane protein function; Inhibition of LPS biosynthesis or function

03

Biological functions

Physical barrier to host defensesBarrier to antibiotics and toxic compoundsFacilitates bacterial adhesion (via adhesins and fimbriae/pili)Supports secretion of virulence factorsInteracts with host immune systemEnables biofilm formationOther
04

Disease associations

Infection (urinary tract infection, pyelonephritis, cystitis)Immune evasionAntibiotic resistanceOther
05

Safety considerations

Development of antibiotic resistancePotential immune hypersensitivity to LPS (e.g., endotoxin shock)Host tissue damage due to excessive inflammationBiofilm-associated persistence and chronic infection
06

Interacting drugs

Polymyxins (e.g., colistin, polymyxin B)

4 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS)Outer membrane protein A (OmpA)Type 1 fimbriae (fimbrial antigens)Other specific surface antigens (e.g., O-antigen)Virulence factor expression (e.g., genes for adhesins, toxins)

Beyond the preview

Go deeper on Uropathogenic Escherichia coli outer membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uropathogenic Escherichia coli outer membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call